News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,697 Results
Type
Article (61383)
Company Profile (488)
Press Release (650826)
Section
Business (195376)
Career Advice (3479)
Deals (35313)
Drug Delivery (113)
Drug Development (84860)
Employer Resources (177)
FDA (17275)
Job Trends (15447)
News (343118)
Policy (34735)
Tag
Academia (2903)
Alliances (51160)
Alzheimer's disease (1328)
Approvals (17185)
Artificial intelligence (148)
Bankruptcy (346)
Best Places to Work (12123)
Biotechnology (368)
Breast cancer (129)
Cancer (1169)
Cardiovascular disease (106)
Career advice (2944)
Cell therapy (271)
Clinical research (67084)
Collaboration (415)
Compensation (197)
COVID-19 (2722)
C-suite (105)
Data (1153)
Diabetes (167)
Diagnostics (6297)
Drug pricing (98)
Earnings (73485)
Employer resources (155)
Events (112284)
Executive appointments (319)
FDA (17834)
Funding (374)
Gene therapy (204)
GLP-1 (676)
Government (4791)
Healthcare (19900)
Infectious disease (2812)
Inflammatory bowel disease (120)
Interviews (682)
IPO (16333)
Job creations (3749)
Job search strategy (2408)
Layoffs (447)
Legal (7925)
Lung cancer (186)
Manufacturing (196)
Medical device (13408)
Medtech (13412)
Mergers & acquisitions (19070)
Metabolic disorders (463)
Neuroscience (1630)
NextGen Class of 2024 (7160)
Non-profit (4870)
Northern California (1488)
Obesity (267)
Opinion (243)
Patents (107)
People (56191)
Phase I (20816)
Phase II (29453)
Phase III (22113)
Pipeline (467)
Postmarket research (2784)
Preclinical (9058)
Radiopharmaceuticals (258)
Rare diseases (245)
Real estate (5983)
Regulatory (23426)
Research institute (2580)
Resumes & cover letters (564)
Southern California (1320)
Startups (3712)
United States (14007)
Vaccines (631)
Weight loss (213)
Date
Today (43)
Last 7 days (690)
Last 30 days (3735)
Last 365 days (37343)
2024 (34257)
2023 (41471)
2022 (52683)
2021 (57298)
2020 (55914)
2019 (49204)
2018 (37326)
2017 (34532)
2016 (34400)
2015 (39512)
2014 (32436)
2013 (27959)
2012 (29566)
2011 (29960)
2010 (28316)
Location
Africa (1016)
Arizona (166)
Asia (42591)
Australia (7320)
California (3411)
Canada (1289)
China (263)
Colorado (155)
Connecticut (164)
Europe (96878)
Florida (468)
Georgia (117)
Illinois (389)
Indiana (200)
Kansas (97)
Maryland (593)
Massachusetts (2765)
Michigan (164)
Minnesota (274)
New Jersey (982)
New York (986)
North Carolina (798)
Northern California (1488)
Ohio (144)
Pennsylvania (854)
South America (1348)
Southern California (1320)
Texas (473)
Washington State (382)
712,697 Results for "the alliance for regenerative medicine arm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Press Releases
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
September 27, 2024
·
8 min read
Gene therapy
Patient Death in Rett Syndrome Trial Forces Neurogene to Drop High-Dose Arm
Despite the death, the FDA has allowed Neurogene to forge ahead with the Phase I/II Rett syndrome trial, but using only the lower 1E15 vg dose of its investigational gene therapy NGN-401.
November 22, 2024
·
2 min read
·
Tristan Manalac
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Press Releases
Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medicine
November 20, 2024
·
3 min read
Press Releases
CIRM Marks 20 Years of Advancing Regenerative Medicine in California
November 15, 2024
·
3 min read
XNK Therapeutics to present at Redeye Regenerative Medicine/Cell Therapy event
XNK Therapeutics AB announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy event on February 14.
February 8, 2024
·
1 min read
Press Releases
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
October 31, 2024
·
6 min read
Business
Meeting on the Mesa to Highlight Cell and Gene Therapy Opportunities, Challenges
Stephen Majors from the Alliance for Regenerative Medicine, which hosts the conference, spoke with
BioSpace
about what the more than 2,000 attendees can expect to learn next week in Phoenix about the pressing issues confronting the industry.
October 3, 2024
·
7 min read
·
Greg Slabodkin
Cell and gene therapy
Cell and Gene Therapy Investment Ticks Up After Hard Few Years
Tim Hunt, CEO of the Alliance for Regenerative Medicine, said Monday at the 2024 Cell & Gene Meeting on the Mesa that investments reached $10.9 billion in the first half of this year—outpacing 2019’s $9.8 billion total—but far below the pandemic peak.
October 8, 2024
·
4 min read
·
Greg Slabodkin
1 of 71,270
Next
